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Abstract Dystrobrevin, a member of the dystrophin family of
proteins, was initially identified as a major tyrosine phosphoryl-
ated synaptic protein in the electric organ of Torpedo californica.
In this paper, we show that the major sites of tyrosine
phosphorylation of Torpedo dystrobrevin are within its C-
terminus, on Tyr-693 and Tyr-710. Cloning of the mammalian
homologue of dystrobrevin has recently shown that this
phosphotyrosine containing tail, or PYCT, is subject to
alternative splicing. To compare the expression and distribution
of PYCT3 and PYCT+ splice variants, we generated antibodies
against different regions of dystrobrevin. Here we show that the
PYCT3 isoform of 62 kDa is expressed at high levels in all
tissues examined. In contrast, PYCT+ isoforms are expressed
primarily in brain and muscle, where they are concentrated at
synapses. Moreover, PYCT+ isoforms associate more tightly
with the membrane and with syntrophin, another synaptically
enriched protein. These results suggest that PYCT+ isoforms of
dystrobrevin are specialized components of the dystroglycan
complex which render the complex sensitive to regulation by
tyrosine kinases.
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1. Introduction
Synapses are areas of contact between cells which are highly
specialized for the transmission of chemical signals [1]. To
maximize sensitivity during signaling, neurotransmitter recep-
tors and other proteins involved in signal transduction are
concentrated precisely beneath the sites of neurotransmitter
release. The synaptic cytoskeleton is thought to immobilize
the signal transduction apparatus and hence maintain and
modulate the structure of the synapse [2]. The electric organ
of Torpedo californica, a modi¢ed cholinergic synapse and
abundant source of synaptic proteins, has greatly facilitated
the biochemical study of the synaptic cytoskeleton. Alkaline
extracts of membranes prepared from this tissue are enriched
in several proteins including rapsyn, syntrophin, dystrobrevin
(formerly known as 87K) and dystrophin [3,4]. The functional
importance of rapsyn is evident from the failure of neuro-
transmitter receptors and other synaptic proteins to cluster
at the neuromuscular junctions (NMJs) of rapsyn de¢cient
mice [5]. Although syntrophin, dystrobrevin and dystrophin
have been shown to be part of a protein complex localized to
the synapse [3,6^9], the roles of these proteins in synaptic
function is less clear.
Dystrophin was ¢rst identi¢ed as the product of the Du-
chenne’s muscular dystrophy gene [10]. It is a 427-kDa pro-
tein, expressed primarily in muscle, with several domains: an
N-terminal actin-binding domain; a central rod domain con-
taining a number of spectrin like repeats; and, ¢nally, a cys-
teine rich C-terminus, referred to as the CRCT [11]. A com-
plex of proteins, collectively termed the dystrophin-associated
proteins, copurify with dystrophin isolated from rabbit skel-
etal muscle [12]. This complex includes several transmembrane
proteins including the extracellular glycoprotein K-dystrogly-
can, which binds extracellular matrix proteins such as laminin
[13], as well as several peripheral membrane proteins, includ-
ing the rabbit homologues of syntrophin [14] and dystrobrevin
[15].
The components of the dystrophin complex are encoded by
multiple related genes which are subject to alternative splicing
(reviewed in [16]). For example, in addition to dystrophin,
which is itself subject to extensive alternative splicing, there
exists the structurally analogous utrophin which also contains
an actin binding domain, a spectrin repeat region and a
CRCT [17]. The dystrophin family also includes dystrobrevin
with its various splice isoforms [18^20], and the closely related
protein L-dystrobrevin [21]. Similarly, three di¡erent syntro-
phin genes have been identi¢ed, at least two of which are
subject to alternative splicing [22^24].
The various isoforms of the dystrophin complex show dif-
ferential tissue expression. Interestingly, it appears that some
isoforms are synapse speci¢c. For example, in muscle, while
dystrophin and K1- and L1-syntrophin are expressed through-
out the sarcolemma, utrophin and L2-syntrophin appear to be
restricted to the NMJ [9,21,25]. The extensive diversity of the
dystrophin complex suggests that these complexes may have
some specialized, regulated function which varies with cell
type and subcellular location, particularly at the synapse.
The synapse contains specialized membrane and cytoskele-
tal domains which are assembled during synaptogenesis [26].
Reorganization of the post-synaptic membrane at the NMJ is
induced by neuronal agrin, an extracellular matrix molecule
released by the presynaptic nerve terminal and deposited in
what becomes the synaptic basal lamina [27]. Studies using
cultured muscle cells have shown that agrin induces the ag-
gregation of the acetylcholine receptor (AChR) [28]. Such
aggregation is accompanied by AChR tyrosine phosphoryla-
tion and is blocked by tyrosine kinase inhibitors [29,30].
Moreover, recent studies have shown that agrin regulates
the activity of MuSK, a muscle-speci¢c receptor tyrosine kin-
ase that is essential for proper synapse formation [31,32].
These data suggest that tyrosine phosphorylation plays an
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important role in the organization of the synaptic cytoskele-
ton at the NMJ.
One major phosphotyrosine containing component of the
synaptic membranes from Torpedo is the dystrophin-associ-
ated protein dystrobrevin [18,33]. Analysis of the amino acid
sequence of dystrobrevin reveals several tyrosine kinase con-
sensus sites on the C-terminal tail (the phosphotyrosine con-
taining tail, or PYCT), a region of the molecule subject to
alternative splicing [19,20,33]. Because not all splice variants
of dystrobrevin contain the PYCT, di¡erential splicing could,
in theory, confer tissue-speci¢c sensitivity to extracellular sig-
nals mediated by tyrosine kinases.
In this study, we examine the function of the PYCT domain
of dystrobrevin. First, we demonstrate that the two major
sites of tyrosine phosphorylation of dystrobrevin are Tyr-
693 and Tyr-710 ^ both of which are contained within the
PYCT. We show that, while PYCT3 isoforms are highly
abundant and ubiquitously expressed in all tissues, PYCT
isoforms are expressed predominantly in brain and muscle
where they are localized to the synapse. Moreover, PYCT
isoforms are more tightly associated with the membrane than
PYCT3 isoforms. Finally, PYCT isoforms are associated
with syntrophin to a greater degree than the PYCT3 isoforms.
Taken together, these results suggest that alternative splicing
at the PYCT plays a role in regulating subcellular distribution
of dystrobrevin and may regulate the sensitivity of dystrobre-
vin to tyrosine kinase mediated signaling.
2. Materials and methods
2.1. Materials
Post-synaptic membranes from electric organ were prepared as de-
scribed previously [34]. Leupeptin, antipain, chymostatin, and pepsta-
tin were obtained from Chemicon; aprotinin from Miles. All chem-
icals were obtained from Sigma unless otherwise noted.
2.2. Constructs
Torpedo dystrobrevin was polymerase chain reaction (PCR) ampli-
¢ed using the 5P primer ACGCGTCGACAATGGTGAAAACTGC-
AGAAATGATTG and either the 3P primer GAAGATCTTGTCAA-
TGAATCTTGAGGTGTATG (myc-wt) or GAAGATGATCTTCA-
CCCCTGCAAACTGACCTG (myc-vCT), and subcloned in frame
into a PRK5 expression vector with a 5P myc epitope tag.
Mutagenesis was performed using the Chameleon kit (Strata-
gene), according to the manufacturer’s protocol using the following
antisense primers: CATCTGTTCTAACAAAGCTTTCACCATCT-
TC (Y685F), GGACAGATTCATTTTCAAAGCTTTCATCATCTG
(Y693F), GCAGTTTTTGTTTCAGGAATTCTTCCAGTTTTGACT
(Y710F), or GTTCACCCCTGCAAGCTTACCTGAAAGTTCTCA-
TCCTGCAG (Y720F); and the selection primer, GCCAGTGCCA-
AGCTGATATCAGCTTTTTGC. Mutagenesis was con¢rmed by se-
quencing.
To create the wild-type and mutant fusion proteins corresponding
to the PYCT of dystrobrevin, the region corresponding to amino
acids 604^726 of dystrobrevin was ampli¢ed from the myc-PRK5
dystrobrevin constructs. The resulting products were subcloned in
frame into the vectors pGEX4T2 (WT, Y685F and Y710F) or
pGEX2T (Y693F) from Pharmacia to create glutathione-S-transferase
fusion proteins.
2.3. Fusion proteins
The fusion proteins were produced essentially as described [35].
Brie£y, the constructs were transformed into E. coli strain BL21.
An overnight culture was diluted 1:80, and grown to an OD of ap-
proximately 0.5. The culture was induced with 0.5 mg/ml IPTG (Gib-
co-BRL), and grown for an additional 4 h. The cells were harvested
by centrifugation and resuspended in lysis bu¡er (PBS/5 mM EDTA/1
mM DTT/10 U/ml aprotinin) supplemented with additional protease
inhibitors, or INH (0.1 mM phenylmethylsulfonyl£uoride/10 Wg/ml
antipain, leupeptin, chymostatin and pepstatin). After sonication, Tri-
ton X-100 (BioRad) was added to 1%. The lysate was incubated on ice
for 30 min, and centrifuged for 20 min at 700Ug at 4‡C in an HS4
rotor. The supernatant was then adsorbed to glutathione agarose for
at least 60 min. After extensive washing with lysis bu¡er, the agarose
was eluted in lysis bu¡er and INH, with 10 mM reduced gluta-
thione.
2.4. Antibodies
The anti-DHD polyclonal antiserum was generated against a glu-
tathione-S-transferase fusion protein encoding amino acids 291^391
of Torpedo dystrobrevin as described previously [18]. The anti-PYCT
antibody was made by injecting puri¢ed, dialyzed PGEX4T/WT fu-
sion protein into New Zealand white rabbits (Hazelton). Both anti-
bodies were a⁄nity puri¢ed on fusion protein columns. Polyclonal
antiphosphotyrosine antibodies were prepared as described previously
[34]. Anti-syntrophin antibodies (MAb 1351) were a generous gift of
Dr. Stanley Froehner.
2.5. Phosphorylation of post-synaptic membranes
Post-synaptic membranes, enriched in AChR and other post-synap-
tic proteins were prepared from Torpedo californica and phosphory-
lated in vitro, essentially as described in [18]. Postsynaptic membranes
(10 mg) were incubated in 20 ml of phosphorylation bu¡er (20 mM
Tris, pH 7.5, 20 mM MgCl2, 2 mM MnCl2, 1 mM EGTA, 1 mM
EDTA, 1 mM ouabain, 1 mM sodium orthovanadate, 1 mM DTT,
1 WM Walsh protein kinase inhibitor peptide, and 20 Wg/ml each of
antipain, leupeptin, aprotinin, chymostatin and pepstatin). Phospho-
rylation was initiated with the addition of 50 WM [Q-32P]ATP (2200
cpm/pmol). The reaction was allowed to proceed 60 min at 30‡C.
Membranes were collected by centrifugation for 20 min at
66 000Ug at 4‡C, and resuspended by sonication in 5.8 ml of immu-
noprecipitation bu¡er, or IPB (PBS/5 mM EDTA/5 mM EGTA/10
mM sodium pyrophosphate/5 mM sodium £uoride (Mallinkrodt)/1
mM sodium orthovanadate). Triton X-100 was added to a ¢nal con-
centration of 1.3% and the membranes were incubated on ice for 20
min. The insoluble material was removed by centrifugation at
16 000Ug in a refrigerated microcentrifuge. The supernatant was
then incubated with 60 Wl of anti-DHD crude antiserum or pre-im-
mune serum and 900 Wl of a 2U slurry of protein A-Sepharose in
IPB+1% BSA for 3 h at 4‡C. After washing 5 times with 6 ml of
IPB+1% Triton X-100, the beads were eluted by boiling in 2U gel
sample bu¡er, and subjected to SDS-PAGE. The proteins of interest
were subjected to peptide mapping.
2.6. Fusion protein phosphorylation
Fusion protein (1^5 Wg) was incubated in 100 Wl phosphorylation
bu¡er with 0.1 mM DTT, and 35 WM [Q-32P]ATP (2000 cpm/pmol),
1 Wl of pp60cÿsrc kinase (Upstate Biotechnology) for 90 min at 30‡C.
The reaction was stopped by boiling in gel sample bu¡er. The fusion
proteins were then subjected to SDS-PAGE and autoradiography.
2.7. Peptide mapping
The phosphorylated proteins were excised and digested with trypsin
at 0.15 mg/ml; the resulting phosphopeptides were separated by elec-
trophoresis and ascending chromatography and subjected to autora-
diography as previously described [35].
2.8. Phosphorylation of dystrobrevin in pervanadate stimulated
293T cells
Myc-tagged dystrobrevin constructs subcloned in PRK5 were trans-
fected into HEK-293 cells by calcium phosphate coprecipitation using
20 Wg of DNA per 10-cm dish. Forty-eight hours following transfec-
tion the cells were harvested. Pervanadate stimulation of the cells was
performed immediately prior to harvest: 0.3% hydrogen peroxide in
10 mM sodium orthovanadate was diluted 100-fold into the media
and incubated at 37‡C for 10 min. All plates were rinsed twice in
warm PBS, and scraped into 150 Wl of IPB+2% SDS, sonicated and
boiled. After boiling, 750 Wl of cold IPB+INH was promptly added
and the ¢nal detergent concentration was adjusted to 1% Triton. After
incubating 20 min on ice, the insoluble fraction was removed by
centrifugation at 100 000Ug. The supernatant was precleared with
100 Wl of a 2U slurry of protein A-Sepharose (Pharmacia), and
then incubated with 5 Wl of 9E10 anti-myc ascites [36] and 100 Wl of
the 2U Protein A slurry. After 3 h at 4‡C, the beads were washed
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3 times in IPB/1% Triton X-100, and eluted by boiling in gel sample
bu¡er.
The immunoprecipitated proteins were subjected to SDS-PAGE,
transferred to PVDF membranes (Millipore), and immunoblotted
with polyclonal anti-phosphotyrosine antibodies at a 1:500 dilution
or a⁄nity puri¢ed anti-DHD antibodies at 1:10 000.
2.9. Sample preparation and immunoblotting
Homogenates were obtained by homogenizing various tissues in
IPB supplemented with protease inhibitors, and clarifying by centrif-
ugation for 20 min at 1000Ug at 4‡C. Muscle and brain homogenates
were then centrifuged for 15 min at 100 000Ug at 4‡C. The super-
natant was retained as the cytosol, and the pellet, after rinsing once
with IPB, was retained as the crude membrane pellet. Synaptic mem-
branes were puri¢ed from electric organ and brain as described pre-
viously [18,37].
Protein concentration was determined by Coomassie protein assay
(Pierce). Samples were subjected to SDS-PAGE, transferred to PVDF
and immunoblotted using anti-PYCT or anti-DHD at 1:100 dilution,
unless otherwise indicated, in the presence or absence of 0.5 Wg/ml
fusion protein, followed by HRP conjugated anti-rabbit antibodies
(Amersham) and ECL detection (NEN Life Science). Where indi-
cated, blots were stripped and reprobed according to the manufactur-
er’s protocol (NEN Life Science).
2.10. Immunohistochemistry
An adult rat was sacri¢ced, the soleus muscle was dissected out and
snap-frozen in an isopentane dry ice bath. The muscle was embedded
in OCT medium (Tissue-Tek) and 8-Wm sections were cut, washed
with PBS and ¢xed in 2% paraformaldehyde/2% sucrose in PBS for
15 min. The sections were then permeabilized in 0.5% Triton in PBS
for 10 min, blocked in 10% normal goat serum in PBS for more than
1 h at 37‡C and then incubated in primary antibody at 1:50 dilution
in 3% normal goat serum in PBS overnight at 4‡C. The sections were
then washed three times in PBS and then incubated with rhodamine
anti-rabbit antibody and £uorescein K-bungarotoxin in 3% normal
goat serum/PBS for 1 h at room temperature. After washing exten-
sively with PBS, sections were mounted in Immunon containing 30
Wg/ml 1,4-diazabicyclo [2.2.2]-octane and viewed on a Zeiss immuno-
£uorescence microscope. All steps were performed at room temper-
ature unless otherwise indicated.
2.11. Co-immunoprecipitation of dystrobrevin with syntrophin
Crude rat brain homogenates (750 Wg) were solubilized in 1 ml of
2% Triton/IPB+INH on ice for 20 min. After centrifugation at 40 000
rpm for 10 min at 4‡C in a TLA 100.3 rotor, 3 Wg of anti-syntrophin
antibody and 100 Wl of a 2U slurry of anti-mouse IgG Sepharose
(Sigma) was added to the supernatant, and incubated 3 h with rocking
at 4‡C. After washing twice with IPB+500 mM NaCl+1% Triton X-
100, and twice with IPB+1% Triton X-100, the bound proteins were
eluted with gel sample bu¡er and subjected to SDS-PAGE, trans-
ferred to PVDF and immunoblotted as described above.
3. Results
3.1. Identi¢cation of the tyrosine phosphorylation sites of
dystrobrevin
Dystrobrevin is a major tyrosine phosphorylated protein
in Torpedo electric organ [18]. As shown in Fig. 1, it is
comprised of a region homologous to the CRCT of dys-
trophin and the PYCT, which contains several phosphotyro-
sine consensus sites [18]. To identify the sites of dystrobrevin
phosphorylation in Torpedo, dystrobrevin was phosphorylated
by endogenous kinases present in Torpedo electric organ syn-
aptic membranes by incubating the membranes with
[Q-32P]ATP. Phosphorylated dystrobrevin was immunoprecipi-
tated (Fig. 2A) and digested with trypsin. The resulting phos-
phopeptides were resolved by two-dimensional phosphopep-
tide mapping which revealed three major phosphopeptides
(Fig. 2B).
Because the consensus sites for tyrosine phosphorylation
were present in the PYCT region of dystrobrevin, a gluta-
thione-S-transferase-fusion protein encoding the PYCT was
generated, phosphorylated in vitro using the tyrosine kinase,
pp60cÿsrc, and subjected to phosphopeptide mapping. The re-
sulting phosphopeptide map contained four reproducible ma-
jor phosphopeptides (Fig. 2C, and schematically, Fig. 2D),
including three which comigrated with phosphopeptides ob-
tained by phosphorylation of native dystrobrevin with Torpe-
do synaptic kinases. These ¢ndings suggested that the major
sites of dystrobrevin tyrosine phosphorylation are contained
within the PYCT.
To determine the exact sites of phosphorylation, fusion
proteins containing single tyrosine to phenylalanine mutations
were constructed, phosphorylated and subjected to peptide
mapping. As shown in the lower panels of Fig. 2B, mutation
of Tyr-685 to phenylalanine eliminated phosphopeptide 4. In
addition, mutation of Tyr-693 to phenylalanine eliminated
phosphopeptide 3 while mutation of Tyr-710 to phenylalanine
resulted in the removal of phosphopeptides 1 and 2 (Fig.
2F,G). These results indicated that Tyr-693 and Tyr-710
are the major sites of tyrosine phosphorylation by endogen-
ous synaptic tyrosine kinases. Tyr-685, although not highly
phosphorylated in synaptic membrane preparations in vitro,
may yet represent an additional target for tyrosine kinases in
vivo.
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Fig. 1. Domains of dystrobrevin and the corresponding region of dystrophin. Dystrobrevin shows sequence homology to the cysteine rich re-
gion and carboxy terminus (CRCT) of dystrophin, de¢ning it as a member of the dystrophin family. The carboxy terminus contains two re-
gions predicted to form K-helices, denoted h1 and h2. The regions shown to interact with L-dystroglycan and syntrophin are indicated. Torpedo
dystrobrevin and some mammalian splice variants of dystrobrevin (PYCT) have a unique C-terminus containing tyrosine phosphorylation con-
sensus sites, while others do not (PYCT3). The fusion proteins used to generate the anti-DHD (dystrophin homologous domain) and anti-
PYCT (phosphotyrosine containing tail) antisera are bracketed.
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3.2. Phosphorylation in 293T cells
To determine whether the tyrosine residues identi¢ed as
sites of phosphorylation in vitro were also phosphorylated
in intact cells, myc-tagged Torpedo dystrobrevin was ex-
pressed in 293T cells (Fig. 3). Dystrobrevin did not appear
to be basally tyrosine phosphorylated in 293T cells. However,
treatment of myc-dystrobrevin transfected 293T cells with the
protein tyrosine phosphatase inhibitor, pervanadate, dramat-
ically increased the phosphotyrosine content of dystrobrevin.
Moreover, deletion of the PYCT region from dystrobrevin
eliminated tyrosine phosphorylation in this system. Interest-
ingly, Tyr-693 seemed to be the major site of phosphorylation
in pervanadate treated 293T cells since mutation of this tyro-
sine to phenylalanine consistently abolished most of the ob-
served tyrosine phosphorylation of dystrobrevin (myc-
87Y693F). Mutation of Tyr-685 also reduced dystrobrevin
phosphorylation. Thus, in 293T cells, as in electric organ,
the PYCT is the major site of tyrosine phosphorylation.
3.3. Tissue and subcellular distribution of dystrobrevin
While dystrobrevin is a major tyrosine phosphorylated pro-
tein in Torpedo electric organ, the PYCT, and hence the po-
tential for regulation by tyrosine phosphorylation, is not
present in all splice variants of mammalian dystrobrevin (see
Fig. 1). In order to examine the distribution of PYCT3 and
PYCT dystrobrevin, we immunoblotted homogenates of var-
ious rat tissues with antibodies directed toward either the
dystrophin homologous domain (anti-DHD) or the PYCT
(anti-PYCT) (see Fig. 1). Neither antibody is speci¢c for a
particular isoform (i.e. they are insensitive to various splicing
within the CRCT) and the anti-DHD antibody may cross-
react with the closely related L-dystrobrevin; nonetheless,
the anti-DHD antibody recognizes both PYCT3 and PYCT
isoforms, while the anti-PYCT antibody recognizes only
PYCT isoforms.
As shown in Fig. 4, both antibodies recognized a 97-kDa
species in Torpedo electric organ homogenate (TEO). In rat,
the predominant isoform recognized by the anti-DHD anti-
body was 62 kDa which is expressed at similar levels in all
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Fig. 3. Phosphorylation of dystrobrevin transiently expressed in
HEK-293 cells. HEK-293 cells were either mock transfected or tran-
siently transfected with the indicated wild-type or mutant myc-
tagged Torpedo dystrobrevin cDNAs. Cells were treated with (+) or
without (3) pervanadate for 10 min (unless otherwise indicated),
lysed and immunoprecipitated with anti-myc antibodies. After reso-
lution with SDS-PAGE and transfer to a PVDF membrane, immu-
noblotting was performed with anti-phosphotyrosine antibodies (top
panel). Subsequently, the PVDF was stripped and reprobed with
anti-dystrobrevin antibodies to assess levels of expression (bottom
panel).
Fig. 2. Determination of the tyrosine phosphorylation sites on Torpedo dystrobrevin. A: Immunoprecipitation. Torpedo electric organ postsyn-
aptic membranes (1 mg) were phosphorylated in vitro by endogenous kinases using [Q-32P]ATP and solubilized. Dystrobrevin was immunopre-
cipitated using anti-DHD antibodies (I) or pre-immune serum (P), subjected to SDS-PAGE, and visualized by autoradiography. B^G: Phospho-
peptide analysis. Following phosphorylation and immunoprecipitation, 32P-labeled dystrobrevin was digested with trypsin and the resulting
phosphopeptides were separated by electrophoresis in one dimension and ascending chromatography in the second. To map the sites of phos-
phorylation, wild-type (C) and mutant (E^G) fusion proteins corresponding to the PYCT domain of Torpedo dystrobrevin were constructed.
Puri¢ed fusion proteins were phosphorylated in vitro by recombinant src protein kinase, subjected to SDS-PAGE, autoradiography and trypsin
digestion. The resulting phosphopeptides were analyzed as above. The four major phosphopeptides are depicted schematically (D).
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tissues. The predominant isoform recognized by the anti-
PYCT antibody, on the other hand, was a 90-kDa protein
in brain (Fig. 4, lower panel) with a 97-kDa protein also
detected in skeletal muscle with longer exposures. Consistent
with the complex distribution of dystrobrevin splice variants
by Northern analysis [19,20], multiple other PYCT and
PYCT3 isoforms could also be detected with long exposures
and increased antibody concentrations (data not shown).
Under such conditions, the anti-DHD antibody recognized
the 90-kDa and 97-kDa isoforms; the anti-PYCT antibody,
on the other hand, did not react with the 62-kDa isoform
under any conditions examined. The speci¢city of these inter-
actions was con¢rmed by blocking them with the immunizing
fusion proteins ((+FP), and data not shown).
The fact that higher antibody concentrations and exposure
times were necessary for the detection of the 90- and 97-kDa
PYCT dystrobrevin isoforms by the anti-DHD antibody
suggests that these isoforms are less abundant than the 62-
kDa PYCT3 isoform. Thus, it seems that PYCT3 dystrobre-
vin is ubiquitously expressed at relatively high levels, while
PYCT dystrobrevin is expressed at much lower levels in a
selective pattern, consistent with a more specialized role for
this isoform.
To further characterize the distribution of dystrobrevin iso-
forms, homogenates (H) of electric organ (TEO), brain and
muscle were subjected to subcellular fractionation (Fig. 5).
Upon centrifugation, PYCT isoforms showed greater a⁄nity
for the membrane fraction (M) in all three tissues (Fig. 5). The
PYCT3 isoforms, on the other hand, remained almost entirely
with the cytosol (C), indicating that the PYCT isoforms are
preferentially membrane associated. The 45-kDa band recog-
nized by the anti-DHD antibody in muscle also appeared in
longer exposures of the blot shown in Fig. 4. It may represent
a degradation product of the 62-kDa dystrobrevin isoform.
Alternatively, its size is consistent with the dystrobrevin-N
splice variant described by Sadoulet-Puccio and others, which
is highly expressed in cardiac and skeletal muscle [20].
3.4. Association of PYCT dystrobrevin with synaptic
membranes
To examine the association of PYCT isoforms with syn-
aptic membranes, Torpedo electric organ membranes were
fractionated into non-synaptic, mixed, and synaptic mem-
branes. Both the anti-DHD and anti-PYCT antisera recog-
nized a 97-kDa isoform which was enriched in synaptic mem-
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Fig. 5. Subcellular fractionation of dystrobrevin isoforms. Total homogenates (H) from Torpedo electric organ (TEO), rat brain or rat muscle
were fractionated into membrane (M) and cytosol (C) components. Five micrograms of each were loaded per lane and subjected to SDS-
PAGE and transferred to a PVDF membrane. Immunoblotting was performed using the anti-DHD or anti-PYCT antibodies as labeled. Molec-
ular weight markers are indicated.
Fig. 4. Distribution of dystrobrevin isoforms in various tissues. Five
micrograms of rat tissue homogenates, or 5 Wg (top) and 0.1 Wg
(bottom) of Torpedo electric organ synaptic membranes (TEO) were
subjected to SDS-PAGE, transferred to PVDF membranes and im-
munoblotted with anti-DHD (top) or anti-PYCT (bottom) antibod-
ies. These signals were blocked by preincubation of the antibody
with 3 Wg/ml of the fusion protein used to generate the antibody
(+FP). Molecular weight markers are indicated.
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branes (Fig. 6A), as has been described previously [18]. To
determine whether dystrobrevin was also enriched at central
synapses, synaptic membranes were puri¢ed from total brain
membranes. Fig. 6B shows that the 62-kDa dystrobrevin iso-
form, lacking the PYCT, was not enriched in synaptic mem-
branes. On the other hand, the 90-kDa protein recognized by
the anti-PYCT antiserum was greatly enriched in synaptic
membranes relative to total membranes (Fig. 6C), the latter
requiring longer exposure to detect the 90-kDa isoform (data
not shown). Thus, in brain, as in electric organ, PYCT iso-
forms are enriched in the synaptic membrane.
3.5. Immunocytochemical localization of dystrobrevin
in rat muscle
Previous studies have shown that dystrobrevin in rat skel-
etal muscle is enriched at the NMJ, with lower levels through-
out the sarcolemma [3]. To determine the localization of the
PYCT dystrobrevin isoform, adult rat muscle was double-
labeled with both anti-PYCT antibody and K-bungarotoxin to
localize the nicotinic acetylcholine receptors (Fig. 7). PYCT
dystrobrevin staining (K-PYCT) co-localized with K-bungaro-
toxin staining (K-BT), consistent with a synaptic localization
for this isoform. The speci¢city of immunostaining is demon-
strated by preadsorption of the antibody with the immunizing
fusion protein (Fig. 7, K-BT and K-PYCT+FP).
3.6. Co-immunoprecipitation with syntrophin
The region of dystrobrevin which binds to syntrophin has
been mapped within the CRCT (Fig. 1) [38^40]. To determine
whether the PYCT domain altered the association of dystro-
brevin with syntrophin, syntrophin was immunoprecipitated
from rat brain homogenate using a monoclonal antibody
which recognizes all three isoforms of syntrophin. Consistent
with the results of Blake and others [19], the predominant
isoforms co-immunoprecipitated with anti-syntrophin anti-
bodies are the 90- and 97-kDa isoforms (Fig. 8, K-syn IP).
However, the fact that only trace amounts of these isoforms
relative to the 62-kDa PYCT3 isoform were present in total
rat brain homogenate (Fig. 8, LOAD), demonstrates that the
90-kDa and 97-kDa PYCT isoforms are selectively co-im-
munoprecipitated with anti-syntrophin antibodies. Neither
isoform is immunoprecipitated by a control monoclonal anti-
body (Fig. 8, cMAb IP). Stripping and reprobing this blot
with anti-PYCT antibodies (Fig. 8, right panel) con¢rms
that the 90- and 97-kDa but not the 62-kDa species contains
the PYCT.
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Fig. 6. Distribution of dystrobrevin isoforms in synaptic membranes. A: Torpedo electric organ homogenate was fractionated into cytosol (C)
and crude membranes. The crude membranes were subjected to sucrose gradient sedimentation to yield non-synaptic (N), mixed (M) and syn-
aptic (S) membranes. Western blotting was performed using anti-DHD antibodies (5 Wg protein/lane) or anti-PYCT antibodies (0.2 Wg protein/
lane). The 97-kDa isoform, while present in all membrane fractions, is enriched in synaptic membranes. B: Synaptic membranes were prepared
from crude rat brain membranes by sucrose gradient sedimentation (see Section 2.9). Five micrograms of either total (T) or synaptic mem-
branes (S) were immunoblotted with the indicated antibodies in the absence (3FP) or presence (+FP) of 3 Wg/ml fusion protein block. Molecu-
lar weight markers are indicated.
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4. Discussion
The variety of isoforms which exist for many components
of the dystroglycan complex suggests that the composition of
the dystroglycan complex is highly regulated. By combining
di¡erent isoforms, a variety of tissue and subcellular speci¢c
complexes could be constructed to play distinct functional
roles. In particular, synapse speci¢c dystrophin complexes
may have special properties enabling them to modulate syn-
aptic architecture. Here, evidence is presented that PYCT
dystrobrevin is a synapse speci¢c isoform which is subject to
modulation by tyrosine kinases.
The major sites of tyrosine phosphorylation of Torpedo
dystrobrevin are Y693 and Y710, which are contained within
the PYCT. Interestingly, those isoforms which contain the
PYCT appear to be synapse speci¢c. Immunoblots of various
tissues demonstrate that the 62-kDa (PYCT3) isoform of dys-
trobrevin is widely expressed, while the 90- and 97-kDa iso-
forms are restricted to brain and muscle. The di¡erence be-
tween the 90- and 97-kDa isoforms is unclear but may be due
to alternative splicing at a site outside of the PYCT or to
post-translational modi¢cations such as phosphorylation.
Subcellular fractionation of Torpedo electric organ and rat
brain show that the 62-kDa (PYCT3) dystrobrevin is mostly
soluble while the 90- and 97-kDa (PYCT) isoforms are en-
riched in synaptic membranes. Immunocytochemical staining
of muscle shows that PYCT isoforms of dystrobrevin are
present at the neuromuscular junction, reminiscent of the syn-
aptic distribution of the L2 isoform of syntrophin.
The studies presented here suggest that the presence of this
synaptic form of dystrobrevin may alter the dystrophin com-
plex in several ways. First, PYCT isoforms seem to bind
syntrophin in greater amounts or with higher a⁄nity, since
PYCT isoforms are enriched in syntrophin preparations rel-
ative to PYCT3 isoforms. These results are consistent with
those of Blake et al. [19] which demonstrated that dystrobre-
vin 1 (PYCT) preferentially co-immunoprecipitated with
brain syntrophin compared to dystrobrevin 2 (PYCT3). Sec-
ond, PYCT isoforms are present in membrane fractions,
suggesting that they have additional anchoring sites to the
membrane, that they have a higher a⁄nity for them, or that
they are preferentially bound to isoforms of syntrophin which
have greater membrane a⁄nity.
Finally, the presence of the PYCT makes dystrobrevin an
excellent candidate for regulation by tyrosine phosphoryla-
tion. Analysis of this alternatively spliced PYCT using an K-
helical coiled-coil prediction program reveals a potential
mechanism for the modulation of dystrobrevin function by
tyrosine phosphorylation. Analysis of the sequence for
PYCT itself shows that it has a relatively low propensity to
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Fig. 7. Immuno£uorescence of dystrobrevin in muscle. Muscle sections were double labeled with anti-PYCT antibodies followed by rhodamine-
conjugated anti-rabbit antibodies and FITC conjugated K-bungarotoxin (top right and top left). Pre-incubation of the anti-PYCT antibodies
with 1 Wg/ml fusion protein abolished dystrobrevin staining (lower right) at the endplate visualized with FITC-K-bungarotoxin (lower left).
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form coils (0.233). However, when tyrosines 693 and 710, the
major sites of tyrosine phosphorylation identi¢ed in this pa-
per, are converted to negatively charged amino acids, like
glutamate, the propensity to form coils increases dramatically
(0.999). This is particularly interesting given the ¢nding that
the CRCT present in dystrophin and other family members
also contains two regions predicted to form coils (H1 and H2
in Fig. 1). It has previously been suggested that this region
may mediate heteromeric or homomeric interactions between
members of the dystrophin family [41]. If this is so, the phos-
phorylation of the C-terminus of dystrobrevin may increase its
propensity to coil, creating a new binding site for other dys-
trophin family members.
Thus, PYCT dystrobrevin isoforms are attractive candi-
dates for modulation of the synaptic cytoskeleton. Tyrosine
phosphorylation, induced by such mediators as agrin, may
modulate the a⁄nity of dystrobrevin for other proteins, re-
sulting in alterations in synaptic structure. Moreover, the fact
that PYCT dystrobrevin is highly expressed in brain and
enriched in synaptic membranes suggests that PYCT dystro-
brevin may also play a role in modulating synapses in the
central nervous system.
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Fig. 8. Co-immunoprecipitation of dystrobrevin isoforms with syn-
trophin. Rat brain homogenates (LOAD) were solubilized (see Sec-
tion 2) and subjected to immunoprecipitation with either a control
monoclonal antibody (cMAb IP) or anti-syntrophin (K-syn IP). The
immunoprecipitated proteins were subjected to SDS-PAGE, trans-
ferred to a PVDF membrane and subjected to immunoblotting us-
ing anti-DHD antibody. The blot was subsequently stripped and re-
probed with anti-PYCT antibodies (right panel). The arrow shows
the major species recognized by the anti-PYCT antibody. Molecular
weight markers are indicated.
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